Xu C, Zhang S, Lv J, Cao Y, Chen Y, Sun H
Transl Oncol. 2025; 53:102312.
PMID: 39904282
PMC: 11847097.
DOI: 10.1016/j.tranon.2025.102312.
Zhu X, Huang L, Wang C, Li G, Deng B, Kong D
Nat Commun. 2025; 16(1):723.
PMID: 39820458
PMC: 11739512.
DOI: 10.1038/s41467-025-55852-8.
Wang S, Yang L, Wu Z, Li C, Wang S, Xiao Z
J Transl Med. 2025; 23(1):43.
PMID: 39799354
PMC: 11725224.
DOI: 10.1186/s12967-025-06095-0.
Feng J, Rubbi L, Kianian R, Mills J, Osadchiy V, Sigalos J
Epigenetics. 2024; 19(1):2436304.
PMID: 39637179
PMC: 11622584.
DOI: 10.1080/15592294.2024.2436304.
Huang F, Li K, Chen Z, Cui Z, Hankey W, Fang K
Oncogene. 2024; 44(8):481-493.
PMID: 39613933
DOI: 10.1038/s41388-024-03239-2.
ZBTB7A is a modulator of KDM5-driven transcriptional networks in basal breast cancer.
DiCiaccio B, Seehawer M, Li Z, Patmanidis A, Bui T, Foidart P
Cell Rep. 2024; 43(12):114991.
PMID: 39570746
PMC: 11694571.
DOI: 10.1016/j.celrep.2024.114991.
LTBR acts as a novel immune checkpoint of tumor-associated macrophages for cancer immunotherapy.
Wang L, Fan J, Wu S, Cheng S, Zhao J, Fan F
Imeta. 2024; 3(5):e233.
PMID: 39429877
PMC: 11487550.
DOI: 10.1002/imt2.233.
Vitessce: integrative visualization of multimodal and spatially resolved single-cell data.
Keller M, Gold I, McCallum C, Manz T, Kharchenko P, Gehlenborg N
Nat Methods. 2024; 22(1):63-67.
PMID: 39333268
PMC: 11725496.
DOI: 10.1038/s41592-024-02436-x.
Targeting NAT10 inhibits osteosarcoma progression via ATF4/ASNS-mediated asparagine biosynthesis.
Zou Y, Guo S, Wen L, Lv D, Tu J, Liao Y
Cell Rep Med. 2024; 5(9):101728.
PMID: 39293390
PMC: 11525028.
DOI: 10.1016/j.xcrm.2024.101728.
A comparative analysis of ENCODE and Cistrome in the context of TF binding signal.
Perna S, Pinoli P, Ceri S, Wong L
BMC Genomics. 2024; 25(Suppl 3):817.
PMID: 39210256
PMC: 11363379.
DOI: 10.1186/s12864-024-10668-6.
A single-cell multimodal view on gene regulatory network inference from transcriptomics and chromatin accessibility data.
Loers J, Vermeirssen V
Brief Bioinform. 2024; 25(5).
PMID: 39207727
PMC: 11359808.
DOI: 10.1093/bib/bbae382.
BIT: Bayesian Identification of Transcriptional Regulators from Epigenomics-Based Query Region Sets.
Lu Z, Xu L, Wang X
bioRxiv. 2024; .
PMID: 38895220
PMC: 11185535.
DOI: 10.1101/2024.06.02.597061.
Unveiling the role of HP1α-HDAC1-STAT1 axis as a therapeutic target for HP1α-positive intrahepatic cholangiocarcinoma.
Xiong F, Wang D, Xiong W, Wang X, Huang W, Wu G
J Exp Clin Cancer Res. 2024; 43(1):152.
PMID: 38812060
PMC: 11137995.
DOI: 10.1186/s13046-024-03070-3.
IRF2BP2 counteracts the ATF7/JDP2 AP-1 heterodimer to prevent inflammatory overactivation in acute myeloid leukemia (AML) cells.
Fischer S, Weber L, Stielow B, Frech M, Simon C, Geller M
Nucleic Acids Res. 2024; 52(13):7590-7609.
PMID: 38801077
PMC: 11260449.
DOI: 10.1093/nar/gkae437.
Inferring gene regulatory networks from single-cell multiome data using atlas-scale external data.
Yuan Q, Duren Z
Nat Biotechnol. 2024; 43(2):247-257.
PMID: 38609714
PMC: 11825371.
DOI: 10.1038/s41587-024-02182-7.
Cardiac GR Mediates the Diurnal Rhythm in Ventricular Arrhythmia Susceptibility.
Tikhomirov R, Oakley R, Anderson C, Xiang Y, Al-Othman S, Smith M
Circ Res. 2024; 134(10):1306-1326.
PMID: 38533639
PMC: 11081863.
DOI: 10.1161/CIRCRESAHA.123.323464.
CDCA7-associated global aberrant DNA hypomethylation translates to localized, tissue-specific transcriptional responses.
Vukic M, Chouaref J, Della Chiara V, Dogan S, Ratner F, Hogenboom J
Sci Adv. 2024; 10(6):eadk3384.
PMID: 38335290
PMC: 10857554.
DOI: 10.1126/sciadv.adk3384.
ANKRD1 is a mesenchymal-specific driver of cancer-associated fibroblast activation bridging androgen receptor loss to AP-1 activation.
Mazzeo L, Ghosh S, Di Cicco E, Isma J, Tavernari D, Samarkina A
Nat Commun. 2024; 15(1):1038.
PMID: 38310103
PMC: 10838290.
DOI: 10.1038/s41467-024-45308-w.
HNF4A guides the MLL4 complex to establish and maintain H3K4me1 at gene regulatory elements.
Thakur A, Park K, Cullum R, Fuglerud B, Khoshnoodi M, Drissler S
Commun Biol. 2024; 7(1):144.
PMID: 38297077
PMC: 10830483.
DOI: 10.1038/s42003-024-05835-0.
Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells.
Ozgun G, Yaras T, Akman B, Ozden-Yilmaz G, Landman N, Karakulah G
Cancer Gene Ther. 2024; 31(4):537-551.
PMID: 38233533
DOI: 10.1038/s41417-024-00725-3.